InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease
InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease
inmed pharmaceuticals宣佈INm-901口服制劑將用於其阿爾茨海默病開發項目中。
InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease
inmed pharmaceuticals宣佈INm-901口服制劑將用於其阿爾茨海默病開發項目中。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間